Business Context and Reporting Period
Company: Colgate-Palmolive Company
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2006
Business Overview: The Company operates globally in two primary segments: Oral, Personal and Home Care, and Pet Nutrition. It competes in over 200 countries, focusing on core categories to maximize market leadership and profitability.
Key Financial Metrics
| Metric | Q1 2006 | Q1 2005 |
|---|---|---|
| Net Sales | $2,870.6 million | $2,743.0 million |
| Gross Profit | $1,563.5 million | $1,503.6 million |
| Operating Profit | $517.5 million | $492.6 million |
| Net Income | $324.5 million | $300.1 million |
| Diluted EPS | $0.59 | $0.53 |
| Operating Cash Flow | $382.5 million | $425.0 million |
| Cash and Equivalents (End of Period) | $382.8 million | $413.9 million |
| Total Debt (Current + Long-term) | $3,491.6 million | $3,275.7 million (Dec 31, 2005) |
Margins: Gross profit margin was 54.5% (down from 54.8% in 2005). Operating profit margin remained at 18.0% of sales.
Material Changes vs. Prior Period
- Sales Growth: Net sales increased 4.5% year-over-year, driven primarily by a 4.5% increase in unit volume. Price increases of 1.5% were offset by a 1.5% negative foreign exchange impact.
- Profitability: Operating profit rose 5% to $517.5 million. This growth occurred despite a $65.8 million pretax restructuring charge and a $17.6 million incremental stock-based compensation charge due to the adoption of SFAS 123R.
- Segment Performance:
- Latin America: Sales surged 17.5% and operating profit grew 29%, driven by volume, pricing, and favorable foreign exchange.
- Europe/South Pacific: Sales declined 4.0% due to a 9.0% negative foreign exchange impact, though volume grew 7.5%.
- Pet Nutrition: Sales increased 7.0% with operating profit up 6%.
- Cash Flow: Operating cash flow decreased to $382.5 million from $425.0 million, attributed to higher tax payments and working capital changes (specifically inventory build-up).
Guidance, Outlook, and Risks
Management Commentary & Outlook:
- Restructuring Program: The 2004 Restructuring Program continues, with cumulative pretax charges estimated between $750 million and $900 million. Annual savings are projected to reach $325 million to $400 million by 2008.
- Capital Expenditures: Expected to increase to approximately 4.0% to 4.5% of Net sales in 2006.
- Shareholder Returns: The Board approved a new 30 million share repurchase program and increased the annualized common stock dividend to $1.28 per share.
- Acquisition: Agreed to purchase approximately 84% of Tom's of Maine, Inc. for ~$100 million, expected to close in Q2 2006.
Risks and Contingencies:
- Legal/Tax Matters: Significant ongoing disputes in Brazil regarding the 1995 Kolynos acquisition, including a potential Central Bank fine (~$120 million) and tax assessments (~$95 million). Management intends to challenge these vigorously.
- IRS Audit: Ongoing examination of federal tax returns (1996-2003) regarding expatriate executive compensation deductions. Potential additional tax exposure is estimated at $62 million plus subsequent periods.
- Competition Inquiry: French competition authorities are investigating potential competition law violations; no formal fine has been proposed yet.
Investor Verification Checklist
- Restructuring Impact: Verify the timing and magnitude of future restructuring charges and the realization of projected cost savings.
- Foreign Exchange Sensitivity: Assess the impact of currency fluctuations on reported earnings, particularly in Europe/South Pacific and Latin America.
- Brazilian Legal Exposure: Monitor the status of the Central Bank fine and tax assessments related to the Kolynos acquisition, as these represent significant contingent liabilities.
- Tom's of Maine Integration: Track the closing and integration progress of the Tom's of Maine acquisition.
- Working Capital Trends: Review inventory levels and receivables to ensure the Q1 cash flow decline is not indicative of broader liquidity issues.